Skip to contentSkip to Braille Studio

Library / Laws / 118th Congress / Senate Bills / S. 2079

S. 2079

To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug intended for human use to identify each ingredient in such drug that is, or is derived directly or indirectly from, a major food allergen or a gluten-containing grain, and for other purposes.

Print stageDateSize⠃
Introduced in Senate2023-06-211.6K⠃⠗⠋